Agilus is a medicine used to treat malignant hyperthermia (rapid rise in body temperature caused by uncontrolled muscle contractions) in adults and children. Malignant hyperthermia is a serious reaction to certain medicines used for general anaesthesia during surgery or other medical procedures. Agilus contains the active substance dantrolene and is a ‘hybrid medicine’. This means that it is similar to a reference medicine containing the same active substance, but there are certain differences between the two. Agilus contains a higher amount of the active substance than the reference medicine, and also contains different excipients (ingredients) that make the powder easier to dissolve. The reference medicine for Agilus is Dantrium IV.
Therapeutic Indication
### Therapeutic indication In combination with adequate support measures, Agilus is indicated for the treatment of malignant hyperthermia in adults and children of all ages.
Therapeutic Area (MeSH)
ATC Code
M03CA01
ATC Item
dantrolene
Pharmacotherapeutic Group
MUSCLE RELAXANTS
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| dantrolene sodium, hemiheptahydrate | N/A | dantrolene sodium, hemiheptahydrate |
EMA Name
Agilus
Medicine Name
Agilus
Aliases
N/A